






Medgenics Inc. - Product Pipeline Review - 2015























































  info@wiseguyreports.com  |   
 Chat with us   |    +1 (339) 368 6938 (US)  |     +44 208 133 9349 (UK) 



 Login    Register 






















Home


Report Categories







Premium Reports

Access to 600000+ Premium Reports











  
                                Aerospace & Defense
                              









  
                                Agri & Food
                              









  
                                Automotive
                              









  
                                Basic Materials
                              











  
                                Consumer Goods & Retail
                              









  
                                Energy
                              









  
                                Life Sciences
                              









  
                                Manufacturing & Construction
                              











  
                                Services
                              









  
                                Telecom & IT
                              









  
                                Education
                              









  
                                Security & Intelligence Systems
                              











  
                                Technology
                              









  
                                Company Reports
                              










Report Categories 










Aerospace & Defense
                





Agri & Food
                





Automotive
                





Basic Materials
                







Consumer Goods & Retail
                





Energy
                





Life Sciences
                





Manufacturing & Construction
                







Services
                





Telecom & IT
                





Education
                





Security & Intelligence Systems
                







Technology
                





Company Reports
                








Publisher
Knowledgestore

Countries 
              


Browse by Country
Browse by Continent
Browse by Group / Region



 Conferences
              


Upcoming Conferences
Seminars




 Conferences
              


Upcoming Conferences
Seminars




Countries 

Browse by Country
Browse by Continent
Browse by Group / Region



News & Blog

 Press Release
Blog



News & Blogs

 Press Release
Blogs


FAQs

About Us

About Our Company
Our Team
Life At WGR


Careers
Contact Us











                                         There are no items currently in your basket.
                                     













There are no items currently in your basket!














  




































Search 
                






 














Home
All Reports
Medgenics Inc. - Product Pipeline Review - 2015









 


  Medgenics Inc. - Product Pipeline Review - 2015


WGR210855
30 
                  September, 2015 
Global
26 pages 
Global Markets Direct






















Description




Table of Content




Sample Report




Enquiry before buy




Related Reports





Medgenics Inc. - Product Pipeline Review - 2015
Summary
Global Markets Direct’s, ‘Medgenics Inc. - Product Pipeline Review - 2015’, provides an overview of the Medgenics Inc.’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medgenics Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Medgenics Inc.’s pipeline products
Reasons to buy
- Evaluate Medgenics Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medgenics Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medgenics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues


Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Medgenics Inc. Snapshot 5
Medgenics Inc. Overview 5
Key Information 5
Key Facts 5
Medgenics Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Medgenics Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Medgenics Inc. – Pipeline Products Glance 10
Medgenics Inc. – Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Medgenics Inc. – Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Medgenics Inc. – Drug Profiles 13
MDGN-201 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NFC-1 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MDGN-204 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
MDGN-205 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
MDGN-206 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Medgenics Inc. – Pipeline Analysis 19
Medgenics Inc. – Pipeline Products by Target 19
Medgenics Inc. – Pipeline Products by Route of Administration 20
Medgenics Inc. – Pipeline Products by Molecule Type 21
Medgenics Inc. – Pipeline Products by Mechanism of Action 22
Medgenics Inc. – Recent Pipeline Updates 23
Medgenics Inc. – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26
List of Tables
Medgenics Inc., Key Information 5
Medgenics Inc., Key Facts 5
Medgenics Inc. – Pipeline by Indication, 2015 7
Medgenics Inc. – Pipeline by Stage of Development, 2015 8
Medgenics Inc. – Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. – Phase II, 2015 10
Medgenics Inc. – Phase I, 2015 11
Medgenics Inc. – Preclinical, 2015 12
Medgenics Inc. – Pipeline by Target, 2015 19
Medgenics Inc. – Pipeline by Route of Administration, 2015 20
Medgenics Inc. – Pipeline by Molecule Type, 2015 21
Medgenics Inc. – Pipeline Products by Mechanism of Action, 2015 22
Medgenics Inc. – Recent Pipeline Updates, 2015 23
Medgenics Inc., Other Locations 24
Medgenics Inc., Subsidiaries 24
List of Figures
Medgenics Inc. – Pipeline by Top 10 Indication, 2015 7
Medgenics Inc. – Pipeline by Stage of Development, 2015 8
Medgenics Inc. – Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. – Pipeline by Top 10 Target, 2015 19
Medgenics Inc. – Pipeline by Top 10 Route of Administration, 2015 20
Medgenics Inc. – Pipeline by Top 10 Molecule Type, 2015 21
Medgenics Inc. – Pipeline Products by Top 10 Mechanism of Action, 2015 22







                                Request a Sample Report
                                




Name:*










Email:*


(Optional: Request you to please fill in your Corporate Email-ID)



Job Title:*





Company:*





Phone No:*





Your Country:*

--select country--
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodja
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo-Brazzaville
Congo-Kinshasa
Cook Islands
Costa Rica
Cote d"Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland (Malvinas)
Faroes
Fiji
Finland
France
French-Guiana
Tahiti(French Polinesia)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Vatican City
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Norfolk
Northern Mariana
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Lucia
Saint Pierre and Miquelon
St Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands British
Virgin Islands US
Wales
Western Sahara
Yemen
Zambia
Zimbabwe
Timor-Leste
Curacao
St Kitts & Nevis
Sint Maarten
Guernsey
Isle of Man
Jersey
Niue
Montenegro



Do you have any Specific field of Interest?*

















Confirm


 








Make an enquiry before buying this Report




Name:*










Email:*


(Optional: Request you to please fill in your Corporate Email-ID)



Job Title:*





Company:*





Phone No:*





Your Country:*

--select country--
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodja
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo-Brazzaville
Congo-Kinshasa
Cook Islands
Costa Rica
Cote d"Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland (Malvinas)
Faroes
Fiji
Finland
France
French-Guiana
Tahiti(French Polinesia)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Vatican City
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Norfolk
Northern Mariana
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Lucia
Saint Pierre and Miquelon
St Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands British
Virgin Islands US
Wales
Western Sahara
Yemen
Zambia
Zimbabwe
Timor-Leste
Curacao
St Kitts & Nevis
Sint Maarten
Guernsey
Isle of Man
Jersey
Niue
Montenegro



Your Enquiry*

















Confirm


 
















Purchase this Market Research Report







 USD




 GBP




 EURO




 YEN




 INR







                        1-user PDF
                         
                          $1,500.00
                        

 
                        Site PDF 
                         
                          $3,000.00
                        

 
                        Enterprise PDF 
                         
                          $4,500.00
                        





  1-user PDF
  
 
    1,153.20
   

 
  Site PDF 
  
 
  2,306.40
  

 
  Enterprise PDF 
  
 
  3,459.60
  





  1-user PDF
  
 
    1,290.45
   

 
  Site PDF 
  
 
  2,580.90
  

 
  Enterprise PDF 
  
 
  3,871.35
  





  1-user PDF
  
 
    167,913.00
   

 
  Site PDF 
  
 
  335,826.00
  

 
  Enterprise PDF 
  
 
  503,739.00
  





  1-user PDF
  
 
    96,630.75
   

 
  Site PDF 
  
 
  193,261.50
  

 
  Enterprise PDF 
  
 
  289,892.25
  









Add To Cart
BUY NOW





 















  Email Report


  Sample Report




  Save Page


  Any Questions




  Download information


  Check Discount




  Download Order Form









  Email Report


  Sample Report




  Save Page


  Any Questions




  Download information


  Check Discount




  Download Order Form






Contact Us










Akash Anand
Domain Head Business Development
sales@wiseguyreports.com
+1 (646) 843 9312 (US)
+44 208 133 9349 (UK)













Rishabh Arora
Domain Head Business Development
sales@wiseguyreports.com
+44-208-133-9346













Abu Koshy
Domain Head Business Development
sales@wiseguyreports.com
+1 339 368 6938










Related Reports








                  ×
              
Tell a friend about this report 




Your Name:*





Your Email:*





Friend's Name:*





Friend's Email:*





Your Enquiry*









Send


 



































MEDGENICS.COMMEDGENICS.COMMEDGENICS.COMMEDGENICS.COMMEDGENICS.COM


















Medgenics Inc. - Product Pipeline Review - 2015 Trends, Statistics, Segment and Forecasts, Market Size, Share Analysis : Market Research Store



















+49 322 210 92714
                                    (GMT OFFICE HOURS)
                                

+1-855-465-4651
                                    (US/CAN TOLL FREE)
                                

+1-386-310-3803
                                    (US OFFICE NO)
                                
































Home
Categories
Become Publisher
News
About Us
Contact Us



























-Select Category-
Consumer Goods
Food & Beverage
Heavy Industry
Life Sciences
Marketing & Market Research
Public Sector
Service Industries
Technology & Media
Semiconductor
Chemical and Materials
Metallurgical
Market Research




Search












Home >> Life Sciences >> Pharmaceuticals


Medgenics Inc. - Product Pipeline Review - 2015



Published: Sep-2015 | Format: PDF | Global Markets Direct | Number of pages: 26 | Code: MRS - 37914



Report Details
Table Of Content
Inquiry For Buying
Request Sample



Medgenics Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Medgenics Inc. - Product Pipeline Review - 2015’, provides an overview of the Medgenics Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medgenics Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Medgenics Inc.’s pipeline products

Reasons to buy

- Evaluate Medgenics Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medgenics Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medgenics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues


Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Medgenics Inc. Snapshot 5
Medgenics Inc. Overview 5
Key Information 5
Key Facts 5
Medgenics Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Medgenics Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Medgenics Inc. – Pipeline Products Glance 10
Medgenics Inc. – Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Medgenics Inc. – Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Medgenics Inc. – Drug Profiles 13
MDGN-201 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NFC-1 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MDGN-204 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
MDGN-205 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
MDGN-206 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Medgenics Inc. – Pipeline Analysis 19
Medgenics Inc. – Pipeline Products by Target 19
Medgenics Inc. – Pipeline Products by Route of Administration 20
Medgenics Inc. – Pipeline Products by Molecule Type 21
Medgenics Inc. – Pipeline Products by Mechanism of Action 22
Medgenics Inc. – Recent Pipeline Updates 23
Medgenics Inc. – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26 
List of Tables
Medgenics Inc., Key Information 5
Medgenics Inc., Key Facts 5
Medgenics Inc. – Pipeline by Indication, 2015 7
Medgenics Inc. – Pipeline by Stage of Development, 2015 8
Medgenics Inc. – Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. – Phase II, 2015 10
Medgenics Inc. – Phase I, 2015 11
Medgenics Inc. – Preclinical, 2015 12
Medgenics Inc. – Pipeline by Target, 2015 19
Medgenics Inc. – Pipeline by Route of Administration, 2015 20
Medgenics Inc. – Pipeline by Molecule Type, 2015 21
Medgenics Inc. – Pipeline Products by Mechanism of Action, 2015 22
Medgenics Inc. – Recent Pipeline Updates, 2015 23
Medgenics Inc., Other Locations 24
Medgenics Inc., Subsidiaries 24 
List of Figures
Medgenics Inc. – Pipeline by Top 10 Indication, 2015 7
Medgenics Inc. – Pipeline by Stage of Development, 2015 8
Medgenics Inc. – Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. – Pipeline by Top 10 Target, 2015 19
Medgenics Inc. – Pipeline by Top 10 Route of Administration, 2015 20
Medgenics Inc. – Pipeline by Top 10 Molecule Type, 2015 21
Medgenics Inc. – Pipeline Products by Top 10 Mechanism of Action, 2015 22 

Inquiry For Buying

Please fill your details below, to inquire about this report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit







Request Sample

Please fill your details below, to receive sample report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit











Related Reports


Global Nerve Gas Auto-Injector Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 135 | Code : MRS-151641 | 2800
                    
The Global Nerve Gas Auto-Injector Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Nerve Gas Auto-Injector industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nerve Gas Auto-Injector market study provides comprehensive data which enhances t Read more




Global Parkinson's Disease Drug Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 103 | Code : MRS-151640 | 2800
                    
The Global Parkinson's Disease Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Parkinson's Disease Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Parkinson's Disease Drug market study provides comprehensive data which enhance Read more




Global Minimally Invasive Surgery Video Columns Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 101 | Code : MRS-151639 | 2800
                    
The Global Minimally Invasive Surgery Video Columns Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Minimally Invasive Surgery Video Columns industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Minimally Invasive Surgery Video Columns market Read more




Global Botanical and Plant-Derived Drugs Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 116 | Code : MRS-151638 | 2800
                    
The Global Botanical and Plant-Derived Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Botanical and Plant-Derived Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Botanical and Plant-Derived Drugs market study provides compr Read more




Global Tele-Health Monitoring Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 128 | Code : MRS-151637 | 2800
                    
The Global Tele-Health Monitoring Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Tele-Health Monitoring industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tele-Health Monitoring market study provides comprehensive data which enhances the  Read more




Global Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 100 | Code : MRS-151636 | 2800
                    
The Global Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Pipeline Drugs for Hematopoietic Stem Cell Transplantation industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pipeline Dr Read more




Chlamydia Infections Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 58 | Code : MRS-151584 | 2500
                    
Chlamydia Infections Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H1, 2017" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clini Read more




Childhood Epilepsy Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 132 | Code : MRS-151583 | 2500
                    
Childhood Epilepsy Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H1, 2017" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Childhood Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical tria Read more




Chikungunya Fever Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 41 | Code : MRS-151582 | 2500
                    
Chikungunya Fever Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chikungunya Fever Global Clinical Trials Review, H1, 2017" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials b Read more




Chicken Pox Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 49 | Code : MRS-151581 | 2500
                    
Chicken Pox Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chicken Pox Global Clinical Trials Review, H1, 2017" provides an overview of Chicken Pox clinical trials scenario. This report provides top line data relating to the clinical trials on Chicken Pox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &  Read more








Payment Mode




Single User  | $(USD)1500








Multi User | $(USD)3000








Corporate User  | $(USD)4500













Latest Report


2017 Global Non-Slip Epoxy Glass Flake Paint Market Research Report


2017 Global Parking Sensors Market Research Report


2017 Global Nitrogen Oxide Sensor Market Research Report


2017 Global Nuclear Density Gauge Market Research Report


2017 Global Automotive Interior Materials Market Research Report

View More



Latest News


Global Chitosan Market Set for Rapid Growth, To Reach USD 4.74 Billion by 2021

Zion Market Research has published a new report titled Chitosan Market for Water Treatment, Biomed



Development of e-commerce to Reshape Global Mobile Hotspot Router Market

Mobile hotspot is a popular feature on smart phones that provide wireless internet access on many 



Global Carotenoids Market Is Expected To Reach Around USD 1.52 Billion in 2021

Zion Market Research has published a new report titled Carotenoids Market by Type (Astaxanthin, Be



Soaring Demand from Food & Beverages Industry to Act as Prime Driving for Ascorbic Acid Market, Reports Zion Market Research

Ascorbic acid is extensively available in nature, mostly rich in leafy vegetables and fresh fruits



Global Energy Management System (EMS) Market Is Set for a Rapid Growth and is Expected to Reach USD 63,161.5 million by 2021

Zion Market Research has published a new report titled Energy Management System Market (EMS) by So


View More














Single User | $(USD)1500
View Pricing 













Find Help

How to Order
Disclaimer 
FAQs
Return Policy
Sitemap



Our Company

About Us
Terms and Conditions
Privacy Policy



We accept the following payment methods






© 2016 - 2017 Market Research Store - Market Research Reports 




























Medgenics Inc. - Product Pipeline Review - 2014



















+49 322 210 92714
                                    (GMT OFFICE HOURS)
                                

+1-855-465-4651
                                    (US/CAN TOLL FREE)
                                

+1-386-310-3803
                                    (US OFFICE NO)
                                
































Home
Categories
Become Publisher
News
About Us
Contact Us



























-Select Category-
Consumer Goods
Food & Beverage
Heavy Industry
Life Sciences
Marketing & Market Research
Public Sector
Service Industries
Technology & Media
Semiconductor
Chemical and Materials
Metallurgical
Market Research




Search












Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals


Medgenics Inc. - Product Pipeline Review - 2014



Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 20 | Code: MRS - 18617



Report Details
Table Of Content
Inquiry For Buying
Request Sample




Global Markets Directs, Medgenics Inc. Product Pipeline Review 2014, provides an overview of the Medgenics Inc.s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Medgenics Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Medgenics Inc.s pipeline products
Reasons to buy
Evaluate Medgenics Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Medgenics Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Medgenics Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues


Table Of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Medgenics Inc. Snapshot 4
Medgenics Inc. Overview 4
Key Information 4
Key Facts 4
Medgenics Inc.- Research and Development Overview 5
Key Therapeutic Areas 5
Medgenics Inc.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Medgenics Inc.- Pipeline Products Glance 9
Medgenics Inc.- Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Medgenics Inc.- Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Medgenics Inc.- Drug Profiles 11
MDGN-201 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
MDGN-204 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
MDGN-205 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MDGN-206 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Medgenics Inc.- Pipeline Analysis 15
Medgenics Inc.- Pipeline Products by Target 15
Medgenics Inc.- Pipeline Products by Molecule Type 16
Medgenics Inc.- Recent Pipeline Updates 17
Medgenics Inc.- Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables

Medgenics Inc., Key Information 4
Medgenics Inc., Key Facts 4
Medgenics Inc.- Pipeline by Indication, 2014 6
Medgenics Inc.- Pipeline by Stage of Development, 2014 7
Medgenics Inc.- Monotherapy Products in Pipeline, 2014 8
Medgenics Inc.- Phase I, 2014 9
Medgenics Inc.- Preclinical, 2014 10
Medgenics Inc.- Pipeline by Target, 2014 15
Medgenics Inc.- Pipeline by Molecule Type, 2014 16
Medgenics Inc.- Recent Pipeline Updates, 2014 17
Medgenics Inc., Other Locations 18
Medgenics Inc., Subsidiaries 18

List of Figures

Medgenics Inc. - Pipeline by Top 10 Indication, 2014 6
Medgenics Inc. - Pipeline by Stage of Development, 2014 7
Medgenics Inc. - Monotherapy Products in Pipeline, 2014 8
Medgenics Inc. - Pipeline by Top 10 Target, 2014 15
Medgenics Inc. - Pipeline by Top 10 Molecule Type, 2014 16


Inquiry For Buying

Please fill your details below, to inquire about this report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit







Request Sample

Please fill your details below, to receive sample report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit











Related Reports


Global Nerve Gas Auto-Injector Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 135 | Code : MRS-151641 | 2800
                    
The Global Nerve Gas Auto-Injector Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Nerve Gas Auto-Injector industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nerve Gas Auto-Injector market study provides comprehensive data which enhances t Read more




Global Parkinson's Disease Drug Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 103 | Code : MRS-151640 | 2800
                    
The Global Parkinson's Disease Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Parkinson's Disease Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Parkinson's Disease Drug market study provides comprehensive data which enhance Read more




Global Minimally Invasive Surgery Video Columns Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 101 | Code : MRS-151639 | 2800
                    
The Global Minimally Invasive Surgery Video Columns Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Minimally Invasive Surgery Video Columns industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Minimally Invasive Surgery Video Columns market Read more




Global Botanical and Plant-Derived Drugs Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 116 | Code : MRS-151638 | 2800
                    
The Global Botanical and Plant-Derived Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Botanical and Plant-Derived Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Botanical and Plant-Derived Drugs market study provides compr Read more




Global Tele-Health Monitoring Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 128 | Code : MRS-151637 | 2800
                    
The Global Tele-Health Monitoring Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Tele-Health Monitoring industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tele-Health Monitoring market study provides comprehensive data which enhances the  Read more




Global Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Research Report Forecast 2017 to 2021

Apr-2017 | S&P Consulting | Pages : 100 | Code : MRS-151636 | 2800
                    
The Global Pipeline Drugs for Hematopoietic Stem Cell Transplantation Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Pipeline Drugs for Hematopoietic Stem Cell Transplantation industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pipeline Dr Read more




Chlamydia Infections Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 58 | Code : MRS-151584 | 2500
                    
Chlamydia Infections Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H1, 2017" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clini Read more




Childhood Epilepsy Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 132 | Code : MRS-151583 | 2500
                    
Childhood Epilepsy Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H1, 2017" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Childhood Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical tria Read more




Chikungunya Fever Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 41 | Code : MRS-151582 | 2500
                    
Chikungunya Fever Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chikungunya Fever Global Clinical Trials Review, H1, 2017" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials b Read more




Chicken Pox Global Clinical Trials Review, H1, 2017

May-2017 | GlobalData | Pages : 49 | Code : MRS-151581 | 2500
                    
Chicken Pox Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Chicken Pox Global Clinical Trials Review, H1, 2017" provides an overview of Chicken Pox clinical trials scenario. This report provides top line data relating to the clinical trials on Chicken Pox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 &  Read more








Payment Mode




Single User  | $(USD)1500








Multi User | $(USD)3000








Corporate User  | $(USD)4500













Latest Report


2017 Global Non-Slip Epoxy Glass Flake Paint Market Research Report


2017 Global Parking Sensors Market Research Report


2017 Global Nitrogen Oxide Sensor Market Research Report


2017 Global Nuclear Density Gauge Market Research Report


2017 Global Automotive Interior Materials Market Research Report

View More



Latest News


Global Chitosan Market Set for Rapid Growth, To Reach USD 4.74 Billion by 2021

Zion Market Research has published a new report titled Chitosan Market for Water Treatment, Biomed



Development of e-commerce to Reshape Global Mobile Hotspot Router Market

Mobile hotspot is a popular feature on smart phones that provide wireless internet access on many 



Global Carotenoids Market Is Expected To Reach Around USD 1.52 Billion in 2021

Zion Market Research has published a new report titled Carotenoids Market by Type (Astaxanthin, Be



Soaring Demand from Food & Beverages Industry to Act as Prime Driving for Ascorbic Acid Market, Reports Zion Market Research

Ascorbic acid is extensively available in nature, mostly rich in leafy vegetables and fresh fruits



Global Energy Management System (EMS) Market Is Set for a Rapid Growth and is Expected to Reach USD 63,161.5 million by 2021

Zion Market Research has published a new report titled Energy Management System Market (EMS) by So


View More














Single User | $(USD)1500
View Pricing 













Find Help

How to Order
Disclaimer 
FAQs
Return Policy
Sitemap



Our Company

About Us
Terms and Conditions
Privacy Policy



We accept the following payment methods






© 2016 - 2017 Market Research Store - Market Research Reports 












Medgenics Inc. - Product Pipeline Review - 2015































| Compare 
About Us | 
Contact Us






Home
Research Category
Publisher List
Custom Research
Cart
Compare



Research Category
User Guide
Policies
Contact Us
About us
Site Map











Home > Market Research Report  > Pharmaceutical > Pharmaceutical Companies > Pharma Info









Market Research Report
Medgenics Inc. - Product Pipeline Review - 2015



Published by
Global Markets Direct
Product code
321952


Published
September 30, 2015
Content info
26 Pages 


Price








USD 1500

PDF by E-mail (Single user license)





USD 3000

PDF by E-mail (Site license)





USD 4500

PDF by E-mail (Global license)
























Medgenics Inc. - Product Pipeline Review - 2015



Published: September 30, 2015
Content info: 26 Pages














Description

Summary
Global Markets Direct's, 'Medgenics Inc. - Product Pipeline Review - 2015', provides an overview of the Medgenics Inc.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope

 The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
 The report reviews current pipeline of Medgenics Inc.'s human therapeutic division and enlists all their major and minor projects
 The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
 Special feature on out-licensed and partnered product portfolio
 The report summarizes all the dormant and discontinued pipeline projects
 Latest company statement
 Latest news and deals relating to the Medgenics Inc.'s pipeline products

Reasons to buy

 Evaluate Medgenics Inc.'s strategic position with total access to detailed information on its product pipeline
 Assess the growth potential of Medgenics Inc. in its therapy areas of focus
 Identify new drug targets and therapeutic classes in the Medgenics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
 Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
 Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
 Avoid Intellectual Property Rights related issues




Table of Contents
Product Code: GMDHC07644CDBTable of Contents

Table of Contents 

List of Tables 
List of Figures 

Medgenics Inc. Snapshot 

Medgenics Inc. Overview 
Key Information 
Key Facts 

Medgenics Inc. - Research and Development Overview 

Key Therapeutic Areas 

Medgenics Inc. - Pipeline Review 

Pipeline Products by Stage of Development 
Pipeline Products - Monotherapy 

Medgenics Inc. - Pipeline Products Glance 

Medgenics Inc. - Clinical Stage Pipeline Products 

Phase II Products/Combination Treatment Modalities 
Phase I Products/Combination Treatment Modalities 

Medgenics Inc. - Early Stage Pipeline Products 

Preclinical Products/Combination Treatment Modalities 


Medgenics Inc. - Drug Profiles 

MDGN-201 

Product Description 
Mechanism of Action 
R&D Progress

NFC-1 

Product Description 
Mechanism of Action 
R&D Progress

MDGN-204 

Product Description 
Mechanism of Action 
R&D Progress

MDGN-205 

Product Description 
Mechanism of Action 
R&D Progress

MDGN-206 

Product Description 
Mechanism of Action 
R&D Progress


Medgenics Inc. - Pipeline Analysis 

Medgenics Inc. - Pipeline Products by Target 
Medgenics Inc. - Pipeline Products by Route of Administration 
Medgenics Inc. - Pipeline Products by Molecule Type 
Medgenics Inc. - Pipeline Products by Mechanism of Action 

Medgenics Inc. - Recent Pipeline Updates 
Medgenics Inc. - Locations And Subsidiaries 

Head Office 
Other Locations & Subsidiaries 

Appendix 

Methodology 
Coverage 
Secondary Research 
Primary Research 
Expert Panel Validation 
Contact Us 
Disclaimer 


List of Tables

Medgenics Inc., Key Information 
Medgenics Inc., Key Facts 
Medgenics Inc. - Pipeline by Indication, 2015 
Medgenics Inc. - Pipeline by Stage of Development, 2015 
Medgenics Inc. - Monotherapy Products in Pipeline, 2015 
Medgenics Inc. - Phase II, 2015 
Medgenics Inc. - Phase I, 2015 
Medgenics Inc. - Preclinical, 2015 
Medgenics Inc. - Pipeline by Target, 2015 
Medgenics Inc. - Pipeline by Route of Administration, 2015 
Medgenics Inc. - Pipeline by Molecule Type, 2015 
Medgenics Inc. - Pipeline Products by Mechanism of Action, 2015 
Medgenics Inc. - Recent Pipeline Updates, 2015 
Medgenics Inc., Other Locations 
Medgenics Inc., Subsidiaries 

List of Figures

Medgenics Inc. - Pipeline by Top 10 Indication, 2015 
Medgenics Inc. - Pipeline by Stage of Development, 2015 
Medgenics Inc. - Monotherapy Products in Pipeline, 2015 
Medgenics Inc. - Pipeline by Top 10 Target, 2015 
Medgenics Inc. - Pipeline by Top 10 Route of Administration, 2015 
Medgenics Inc. - Pipeline by Top 10 Molecule Type, 2015 
Medgenics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 








Phone


Int'l: +1-860-674-8796
TollFree(US): +1-866-353-3335
Europe: +32-2-535-7543
Asia: +65-6223-2436


New for 2017 !

GII now purchases any market research reports from any publishers for you.  
			With noextra cost.
Contact us for more details.

FAQ


Delivery Time
User License
Payment Options
Compare Multiple Reports


RELATED REPORTS


Head And Neck Cancer - Pipeline Review, H1 2017 published: May 16, 2017
Alchemia Ltd - Product Pipeline Review - 2016 published: Dec 30, 2016
Array BioPharma Inc - Product Pipeline Review - 2016 published: Dec 30, 2016
Bionomics Ltd - Product Pipeline Review - 2016 published: Dec 30, 2016
Chong Kun Dang Pharmaceutical Corp - Product Pipeline Review - 2016 published: Dec 30, 2016
CSL Ltd - Product Pipeline Review - 2016 published: Dec 30, 2016
Genervon Biopharmaceuticals LLC - Product Pipeline Review - 2016 published: Dec 30, 2016
Genethon SA - Product Pipeline Review - 2016 published: Dec 30, 2016
Hutchison MediPharma Ltd - Product Pipeline Review - 2016 published: Dec 30, 2016
Hyundai Pharmaceutical Co Ltd - Product Pipeline Review - 2016 published: Dec 30, 2016



 ▼


















About
Contact
User Guide
Policies
Site Map



© Copyright 1997-2017, Global Information, Inc. All rights reserved.

























 



 Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc. 
         










    










 













 











 



















Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc.
        																																																		
              
















 News provided by
Aevi Genomic Medicine, Inc.  
Dec 15, 2016, 08:00 ET









 Share this article



























































PHILADELPHIA, Dec. 15, 2016 /PRNewswire/ -- Medgenics, Inc. (NASDAQ:    MDGN) today announced that the company has changed its name to Aevi Genomic Medicine, Inc.  Aevi Genomic Medicine (pronounced "AHH-vee") is a name inspired by the Old Norse language which means "life story" and reflects the Company's mission of improving the lives of children and adults with pediatric onset life-altering diseases.    


"The past year has been a period of transformational change for the company," said Michael F. Cola, President and Chief Executive Officer of Aevi Genomic Medicine. "The name change reflects the company's shift in strategy, our new business model and focus on genomic medicine." 
In conjunction with the corporate name change, the company will trade on the NASDAQ Global Market under the new ticker symbol "GNMX". The new ticker will become effective at the open of the market on December 16, 2016.  In addition, the company will have a new website address: www.aevigenomics.com.
About Aevi Genomic Medicine, Inc.
Aevi Genomics Medicine, Inc. is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverages an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP).  
Forward-looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995, which include all statements other than statements of historical fact, including (without limitation) those regarding the Company's financial position, its development and business strategy, its product candidates and the plans and objectives of management for future operations. The Company intends that such forward-looking statements be subject to the safe harbors created by such laws. Forward-looking statements are sometimes identified by their use of the terms and phrases such as "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning, "expect," "believe," "will," "will likely," "should," "could," "would," "may" or the negative of such terms and other comparable terminology. All such forward-looking statements are based on current expectations and are subject to risks and uncertainties. Should any of these risks or uncertainties materialize, or should any of the Company's assumptions prove incorrect, actual results may differ materially from those included within these forward-looking statements. Accordingly, no undue reliance should be placed on these forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, the events described in the forward-looking statements contained in this release may not occur.
Contacts:
For Media Tonic Life Communications  Melissa Maycott  609-636-3939  melissa.maycott@toniclc.com
For Investors Westwicke Partners Chris Brinzey 339-970-2843 chris.brinzey@westwicke.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medgenics-inc-announces-name-change-to-aevi-genomic-medicine-inc-300378599.html
SOURCE Aevi Genomic Medicine, Inc. 



 
















Jun 13, 2017, 08:00 ET
Preview: Aevi Genomic Medicine to Present at the JMP Securities Life Sciences Conference






My News


  Release contains wide tables.	  View fullscreen.





 Also from this source




 

Jun 13, 2017, 08:00 ET
                                  				                                                                                     
                              Aevi Genomic Medicine to Present at the JMP Securities Life...






 Explore
 More news releases in similar topics

  Health Care & Hospitals
  Medical Pharmaceuticals
  Pharmaceuticals
New Products & Services








 You just read:
Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc.


 News provided by
Aevi Genomic Medicine, Inc.  
Dec 15, 2016, 08:00 ET








 Share this article









































 











Looking to send a news release with PR Newswire?
Take advantage of the world's leading distribution platform.
Sign up to get started
Request more information
Have an account? Log In



















Search











Searching for your content...









Advanced Search












































 


















Aevi Genomic Medicine - Unlocking the potential of genomic medicine



 

This website is best viewed with JavaScript enabled.




aevi


Home
Company
Pipeline
Investors
Careers
Contact






        Unlocking the potential of
        genomic medicine
      




Our Purpose



            Latest News
          




Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life alteringdiseases.



06.13.17
Aevi Genomic Medicine to Present at the JMP Securities Life Sciences Conference


05.10.17
Aevi Genomic Medicine Announces Plans to Initiate Phase 2 Clinical Trial to Confirm Genetic Responders to AEVI-001 and First Quarter 2017 Operating Results


05.03.17
Aevi Genomic Medicine to Host Conference Call to Announce First Quarter and Discuss Recent Business Updates


Read more





Our Management Team
Leaders in genetic science and commercial drug development
Meet the team




Pipeline
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Learn more




Information for Investors
Presentations, information, and news
Learn more



 

Copyright © 2017 Aevi Genomic Medicine, Inc. All rights reserved. Terms of Use | Privacy PolicyAevi Genomic Medicine and the Little Dipper logo are trademarks of Aevi Genomic Medicine, Inc.




 







Medgenics Inc. (MDGN) - Product Pipeline Analysis, 2015 Update
















About Us
Solutions 

Resources

eBooks/White Papers
Slideshares
Videos
Blog


Contact Us
Register
Log in
My Account
Logout














Browse Research










My Cart
















Menu  
                                    





 Close   X














Browse








About Us
Solutions
Resources
Contact Us

Log Out
Register
Log in











Life Sciences»Pharmaceuticals»Pharmaceuticals Company Reports 



Medgenics Inc. (MDGN) - Product Pipeline Analysis, 2015 Update


Lowest Prices Guaranteed
Length
Publisher
Published Date
SKU


from $750
24 Pages


GlobalData




August, 2015
                                

GBDT5693213





Lowest Prices Guaranteed


Price
from $750


Length
24 Pages


Publisher

GlobalData



Published Date

August, 2015

                            


SKU
GBDT5693213



Table of Contents




Close Window
Table of Contents




Medgenics Inc. (MDGN) - Product Pipeline Analysis, 2015 Update


Printer format



GlobalData

Medgenics Inc. Company Snapshot  Medgenics Inc. Company Overview  Key Information  Medgenics Inc. Pipeline Products and Clinical Trials Overview  Medgenics Inc. – Pipeline Analysis Overview  Key Facts  Medgenics Inc. - Major Products and Services  Medgenics Inc. Pipeline Products by Development Stage  Medgenics Inc. Pipeline Products Overview  EPODURE Biopump  EPODURE Biopump Product Overview  HEMODURE Biopump  HEMODURE Biopump Product Overview  INFRADURE  INFRADURE Product Overview  Medgenics Inc. - Key Competitors  Medgenics Inc. - Key Employees  Medgenics Inc. - Locations And Subsidiaries  Head Office  Other Locations & Subsidiaries  Recent Developments  Medgenics Inc., Recent Developments  Aug 10, 2015: Medgenics Reports Second Quarter 2015 Financial Results  Jun 11, 2015: Medgenics Awarded $3.4 Million Grant From the Israeli Office of the Chief Scientist  Jun 10, 2015: Medgenics Announces Appointment of Barbara Duncan to Board of Directors  Jun 04, 2015: Medgenics to Present Clinical Data at the 20th Congress of the European Hematology Association  Apr 17, 2015: Medgenics Reports First Quarter 2015 Financial Results  Feb 13, 2015: Medgenics Reports Fourth Quarter and Full Year 2014 Financial Results  Sep 10, 2014: Medgenics Announces the Appointment of Scott Applebaum as Chief Legal Officer  Jul 16, 2014: Medgenics Reports Second Quarter Financial Results  Jun 18, 2014: Medgenics Announces Global Head, Research and Development, Garry Neil, M.D. Receives FDA Commissioner's Special Citation Award  May 08, 2014: Medgenics Reports First Quarter Financial Results  Appendix  Methodology  About GlobalData  Contact Us  Disclaimer  List of TablesMedgenics Inc., Key Facts  Medgenics Inc. Pipeline Products and Clinical Trials Overview  Medgenics Inc. Pipeline Products by Equipment Type  Medgenics Inc. Pipeline Products by Indication  Medgenics Inc., Key Facts  Medgenics Inc., Major Products and Services  Medgenics Inc. Number of Pipeline Products by Development Stage  Medgenics Inc. Pipeline Products Summary by Development Stage  EPODURE Biopump - Product Status  EPODURE Biopump - Product Description  HEMODURE Biopump - Product Status  HEMODURE Biopump - Product Description  INFRADURE - Product Status  INFRADURE - Product Description  Medgenics Inc., Key Employees  Medgenics Inc., Other Locations  Medgenics Inc., Subsidiaries  List of FiguresMedgenics Inc. Pipeline Products by Equipment Type  Medgenics Inc. Pipeline Products by Development Stage  




Description




Close Window
Description




Medgenics Inc. (MDGN) - Product Pipeline Analysis, 2015 Update


Printer format



GlobalData


SummaryMedgenics Inc. (Medgenics) is a biopharmaceutical company that discovers, develops and commercializes new therapies platform for treating patients with rare genetic and orphan diseases. The company’s products under clinical development includes MDGN-201, MDGN-204, MDGN-205 and MDGN-206. Its products are used for treatment in the therapeutic areas of renal anemia, orphan metabolic syndrome, orphan gi syndrome and orphan enzyme replacement, among others. The company also produces proteins, peptides and other molecules. It has collaborations with other research institutes and companies. Medgenics is headquartered in Wayne, Pennsylvania, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.  The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.Scope:The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developmentsThe report analyzes all pipeline products in development for the company Medgenics Inc.The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch dateThe report provides detailed description of products in development, technical specification and functionsThe report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.Reasons to Buy:Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapeDesign and develop your product development, marketing and sales strategies by understanding the competitor portfolioTo formulate effective Research & Development strategiesDevelop market-entry and market expansion strategiesExploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust returnPlan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etcIdentify, understand and capitalize the next high-value products that your competitor would add in its portfolio





Search inside this report




Close Window
Search inside this report
















Online Download
$750


Purchase






Site License
$1,500


Purchase






Global Site License
$2,250


Purchase










 



Research assistance



US: 800.298.5699
Int'l: +1.240.747.3093
















      Download our eBook: How to Succeed Using Market Research
    

      Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
    

        Download eBook
    



Share this report









Other tasks

Printer format
Order by fax
Currency converter




































 







Medgenics Inc. (MEDG) - Product Pipeline Analysis, 2013 Update
















About Us
Solutions 

Resources

eBooks/White Papers
Slideshares
Videos
Blog


Contact Us
Register
Log in
My Account
Logout














Browse Research










My Cart
















Menu  
                                    





 Close   X














Browse








About Us
Solutions
Resources
Contact Us

Log Out
Register
Log in











Life Sciences»Pharmaceuticals»Pharmaceuticals Company Reports 



Medgenics Inc. (MEDG) - Product Pipeline Analysis, 2013 Update


Lowest Prices Guaranteed
Length
Publisher
Published Date
SKU


from $750
52 Pages


GlobalData




October, 2013
                                

GBDT5146584





Lowest Prices Guaranteed


Price
from $750


Length
52 Pages


Publisher

GlobalData



Published Date

October, 2013

                            


SKU
GBDT5146584



Table of Contents




Close Window
Table of Contents




Medgenics Inc. (MEDG) - Product Pipeline Analysis, 2013 Update


Printer format



GlobalData

Key FactsMedgenics Inc. - Major Products and Services  Medgenics Inc. Pipeline Products by Equipment Type  Medgenics Inc. Pipeline Products by Development Stage  Medgenics Inc. Pipeline Products by Therapy Area  Medgenics Inc. Pipeline Products by Trial Phase  Medgenics Inc. Pipeline Products by Milestone Summary  EPODURE Biopump  EPODURE Biopump Product Status  EPODURE Biopump Product Description  EPODURE Biopump Product Milestone  EPODURE Biopump Clinical Trial  EPODURE Biopump Product Patent Details  HEMODURE Biopump  HEMODURE Biopump Product Status  HEMODURE Biopump Product Description  INFRADURE  INFRADURE Product Status  INFRADURE Product Description  INFRADURE Clinical Trial  INFRADURE Product Patent Details  Medgenics Inc. - Key Competitors  Medgenics Inc. - Key Employees  Medgenics Inc. - Locations And Subsidiaries  Head Office  Other Locations & Subsidiaries  Recent Developments  Medgenics Inc., Recent Developments  Oct 27, 2013: Medgenics Reports Positive Data with Second-Generation Viral Vectors at European Society of Gene and Cell Therapy Congress  Oct 17, 2013: Medgenics Appoints Biopharmaceutical Industry Veteran Bill Gantz to its Board of Directors  Sep 16, 2013: Medgenics Announces New Executive Leadership Team  Aug 06, 2013: Medgenics Reports Second Quarter Financial Results  Jul 09, 2013: Medgenics Awarded $1.9 Million Grant from the Israeli Office of the Chief Scientist  May 09, 2013: Medgenics Reports Q1 2013 Results  Mar 14, 2013: Medgenics Reports 2012 Results  Nov 14, 2012: Medgenics Reports Q3 2012 Results  Aug 14, 2012: Medgenics Appoints Marvin Garovoy As Chief Medical Officer  Aug 13, 2012: Medgenics Reports Q2 2012 Results  AppendixMethodology  About GlobalData  Contact Us  Disclaimer  List of TablesMedgenics Inc., Key Facts  Medgenics Inc. Key Pipeline Products by Equipment Type  Medgenics Inc. Key Pipeline Products by Therapy Area  Medgenics Inc. Key Pipeline Products by Development Stage  Medgenics Inc. Key Pipeline Products by Trial Phase  Medgenics Inc., Key Facts  Medgenics Inc., Major Products and Services  Medgenics Inc. Number of Pipeline Products by Equipment Type  Medgenics Inc. Pipeline Products by Equipment Type  Medgenics Inc. Number of Pipeline Products by Development Stage  Medgenics Inc. Pipeline Products by Development Stage  Medgenics Inc. Number of Pipeline Products by Therapy Area  Medgenics Inc. Pipeline Products by Therapy Area  Medgenics Inc. Number of Pipeline Products by Trial Phase  Medgenics Inc. Pipeline Products by Trial Phase  Medgenics Inc. Number of Pipeline Products By Milestone Summary  Medgenics Inc. Pipeline Products by Milestone Summary  EPODURE Biopump - Product Status  EPODURE Biopump - Product Description  EPODURE Biopump - Product Milestone  EPODURE Biopump - Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in Chronic Kidney Disease Patients Using EPODURE Biopump  EPODURE Biopump - A Phase II B Multi-Center, 100-Patient Clinical Trial Evaluating The Safety And Efficacy Of Sustained Erythropoietin (“EPO”) Therapy Delivered Via EPODURE Biopump  EPODURE Biopump - Patent Details1  EPODURE Biopump - Patent Details2  EPODURE Biopump - Patent Details3  EPODURE Biopump - Patent Details4  EPODURE Biopump - Patent Details5  EPODURE Biopump - Patent Details6  EPODURE Biopump - Patent Details7  EPODURE Biopump - Patent Details8  EPODURE Biopump - Patent Details9  EPODURE Biopump - Patent Details10  EPODURE Biopump - Patent Details11  EPODURE Biopump - Patent Details12  HEMODURE Biopump - Product Status  HEMODURE Biopump - Product Description  INFRADURE - Product Status  INFRADURE - Product Description  INFRADURE - Evaluation of the Safety and Efficacy of the InfraDure Biopump Secreting Sustained Interferon (ALFA-2b) (IFN) on HCV Patients  INFRADURE - Patent Details1  INFRADURE - Patent Details2  INFRADURE - Patent Details3  INFRADURE - Patent Details4  INFRADURE - Patent Details5  INFRADURE - Patent Details6  INFRADURE - Patent Details7  INFRADURE - Patent Details8  INFRADURE - Patent Details9  INFRADURE - Patent Details10  INFRADURE - Patent Details11  INFRADURE - Patent Details12  INFRADURE - Patent Details13  INFRADURE - Patent Details14  INFRADURE - Patent Details15  INFRADURE - Patent Details16  Medgenics Inc., Key Employees  Medgenics Inc., Subsidiaries  List of FiguresMedgenics Inc. Pipeline Products by Equipment Type  Medgenics Inc. Pipeline Products by Development Stage  Medgenics Inc. Pipeline Products by Therapy Area  Medgenics Inc. Pipeline Products by Trial Phase  Medgenics Inc. Pipeline Products by Milestone Summary  




Description




Close Window
Description




Medgenics Inc. (MEDG) - Product Pipeline Analysis, 2013 Update


Printer format



GlobalData


SummaryMedgenics Inc. (Medgenics) is a biopharmaceutical company. The company develops, manufactures and delivers therapeutic protein delivery technology for the treatment of chronic diseases. Its products include is EPODURE Biopump and INFRADURE Biopump and HEMODURE Biopump. Medgenics’s EPODURE Biopump is used in the treatment of anemia. The company’s INFRADURE Biopump is a protein therapy that is designed to produce therapeutic dose of interferon-alpha (IFN-a) for the treatment of hepatitis C. It offers Biopump technology which is a combination of biological/device product. This technology is applied to treat anemia, hepatitis C, growth failure/muscular atrophy, multiple sclerosis , hemophilia, arthritis, wound healing, obesity, chronic pain and cancer recovery. Medgenics is headquartered in San Francisco, California, the US.This report is a source for data, analysis and actionable intelligence on the Medgenics Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.Scope Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. Data on relevant clinical trials and product patent details, wherever applicable. Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.Reasons to Buy Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. Design and develop your product development, marketing and sales strategies. Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies. Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc. Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.





Search inside this report




Close Window
Search inside this report
















Online Download
$750


Purchase






Site License
$1,500


Purchase






Global Site License
$2,250


Purchase










 



Research assistance



US: 800.298.5699
Int'l: +1.240.747.3093
















      Download our eBook: How to Succeed Using Market Research
    

      Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
    

        Download eBook
    



Share this report









Other tasks

Printer format
Order by fax
Currency converter




































 







Pharmaceuticals Market Research Reports & Pharmaceuticals Industry Analysis | MarketResearch.com



















About Us
Solutions 

Resources

eBooks/White Papers
Slideshares
Videos
Blog


Contact Us
Register
Log in
My Account
Logout














Browse Research










My Cart
















Menu  
                                    





 Close   X














Browse








About Us
Solutions
Resources
Contact Us

Log Out
Register
Log in














Market Research
»

Life Sciences

Pharmaceuticals Market Research Reports & Industry Analysis


The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.  The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction. 
...Show More
...Show Less






Filter your search

Filter your search




Anesthesia (60)
Antibiotic (286)
Biopharmaceuticals (236)
Biopharmacology (14)
Clinical Nutrition (91)
Clinical Trial (2322)
Country Overviews (449)
Dietary Supplements (1167)
Diseases & Conditions (6718)
Drug Delivery (221)
Drug Discovery (7825)
General Pharmaceuticals (295)
Generics Drugs (187)
Manufacturing, Packaging & Detailing (4069)
Over-the-Counter Drugs (1626)
Pharmaceuticals Company Reports (4913)
Pharmacy & Distribution (132)
Prescription Drugs (2407)
Pricing (43)
Regulation & Policy (234)
Research & Development (1402)
Technology (20)
Therapeutic Area (8428)
Vaccines (629)




Global  (8324)
Europe  (3964)
Asia  (3234)
North America  (2373)
South America  (360)
Africa  (311)
Oceania  (240)
Middle East  (211)
Caribbean  (34)
Central America  (32)




Research Assistance
US: 800.298.5699 
Int'l: +1.240.747.3093






Join Alert Me Now!
Receive bi-weekly email alerts on new research
Sign Up

Find out more on our blog



Pharmaceuticals Industry Research & Market Reports

Sort by:

Title A-Z
Title Z-A
Price Low-to-High
Price High-to-Low
Date
Date (Older First)

Refine your search




Close Window
Refine your search








Title:







Publisher:







Keyword:







Price(USD):





 To 







Date:



Any Date
Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years





Region:



All Regions

                                                            Africa
                                                        

                                                               Algeria
                                                        

                                                               Angola
                                                        

                                                               Benin
                                                        

                                                               Botswana
                                                        

                                                               Burkina Faso
                                                        

                                                               Burundi
                                                        

                                                               Cameroon
                                                        

                                                               Cape Verde
                                                        

                                                               Central African Republic
                                                        

                                                               Chad
                                                        

                                                               Comoros
                                                        

                                                               The Congo
                                                        

                                                               The Congo
                                                        

                                                               Cote d'Ivoire
                                                        

                                                               Djibouti
                                                        

                                                               Egypt
                                                        

                                                               Equatorial Guinea
                                                        

                                                               Eritrea
                                                        

                                                               Ethiopia
                                                        

                                                               Gabon
                                                        

                                                               The Gambia
                                                        

                                                               Ghana
                                                        

                                                               Guinea
                                                        

                                                               Guinea-Bissau
                                                        

                                                               Kenya
                                                        

                                                               Lesotho
                                                        

                                                               Liberia
                                                        

                                                               Libya
                                                        

                                                               Madagascar
                                                        

                                                               Malawi
                                                        

                                                               Mali
                                                        

                                                               Mauritania
                                                        

                                                               Mauritius
                                                        

                                                               Mayotte
                                                        

                                                               Morocco
                                                        

                                                               Mozambique
                                                        

                                                               Namibia
                                                        

                                                               Niger
                                                        

                                                               Nigeria
                                                        

                                                               Reunion
                                                        

                                                               Rwanda
                                                        

                                                               Sao Tome and Principe
                                                        

                                                               Senegal
                                                        

                                                               Seychelles
                                                        

                                                               Sierra Leone
                                                        

                                                               Somalia
                                                        

                                                               South Africa
                                                        

                                                               South Sudan
                                                        

                                                               Sudan
                                                        

                                                               Swaziland
                                                        

                                                               Tanzania
                                                        

                                                               Togo
                                                        

                                                               Tunisia
                                                        

                                                               Uganda
                                                        

                                                               Western Sahara
                                                        

                                                               Zambia
                                                        

                                                               Zimbabwe
                                                        

                                                            Asia
                                                        

                                                               Afghanistan
                                                        

                                                               Armenia
                                                        

                                                               Azerbaijan
                                                        

                                                               Bangladesh
                                                        

                                                               Bhutan
                                                        

                                                               Brunei
                                                        

                                                               Cambodia
                                                        

                                                               China
                                                        

                                                               Cocos (Keeling) Islands
                                                        

                                                               East Timor
                                                        

                                                               Georgia
                                                        

                                                               Hong Kong
                                                        

                                                               India
                                                        

                                                               Indonesia
                                                        

                                                               Japan
                                                        

                                                               Kazakhstan
                                                        

                                                               Kyrgyzstan
                                                        

                                                               Laos
                                                        

                                                               Macau
                                                        

                                                               Malaysia
                                                        

                                                               Maldives
                                                        

                                                               Mongolia
                                                        

                                                               Myanmar
                                                        

                                                               Nepal
                                                        

                                                               North Korea
                                                        

                                                               Pakistan
                                                        

                                                               Papua New Guinea
                                                        

                                                               Philippines
                                                        

                                                               Russia
                                                        

                                                               Singapore
                                                        

                                                               South Korea
                                                        

                                                               Sri Lanka
                                                        

                                                               Taiwan
                                                        

                                                               Tajikistan
                                                        

                                                               Thailand
                                                        

                                                               Turkey
                                                        

                                                               Turkmenistan
                                                        

                                                               Uzbekistan
                                                        

                                                               Vietnam
                                                        

                                                            Caribbean
                                                        

                                                               Anguilla
                                                        

                                                               Antigua and Barbuda
                                                        

                                                               Aruba
                                                        

                                                               The Bahamas
                                                        

                                                               Barbados
                                                        

                                                               British Virgin Islands
                                                        

                                                               Cayman Islands
                                                        

                                                               Cuba
                                                        

                                                               Curacao
                                                        

                                                               Dominica
                                                        

                                                               Dominican Republic
                                                        

                                                               Grenada
                                                        

                                                               Guadeloupe
                                                        

                                                               Haiti
                                                        

                                                               Jamaica
                                                        

                                                               Martinique
                                                        

                                                               Montserrat
                                                        

                                                               Netherlands Antilles
                                                        

                                                               Puerto Rico
                                                        

                                                               Saint Kitts and Nevis
                                                        

                                                               Saint Lucia
                                                        

                                                               Saint Vincent and the Grenadines
                                                        

                                                               Sint Maarten/ Saint Maarten
                                                        

                                                               Trinidad and Tobago
                                                        

                                                               Turks and Caicos Islands
                                                        

                                                               Virgin Islands
                                                        

                                                            Central America
                                                        

                                                               Belize
                                                        

                                                               Costa Rica
                                                        

                                                               El Salvador
                                                        

                                                               Guatemala
                                                        

                                                               Honduras
                                                        

                                                               Nicaragua
                                                        

                                                               Panama
                                                        

                                                            Europe
                                                        

                                                               Albania
                                                        

                                                               Andorra
                                                        

                                                               Austria
                                                        

                                                               Belarus
                                                        

                                                               Belgium
                                                        

                                                               Bosnia and Herzegovina
                                                        

                                                               Bulgaria
                                                        

                                                               Croatia
                                                        

                                                               Czech Republic
                                                        

                                                               Denmark
                                                        

                                                               Estonia
                                                        

                                                               Faroe Islands
                                                        

                                                               Finland
                                                        

                                                               France
                                                        

                                                               Germany
                                                        

                                                               Gibraltar
                                                        

                                                               Greece
                                                        

                                                               Guernsey
                                                        

                                                               Hungary
                                                        

                                                               Iceland
                                                        

                                                               Ireland
                                                        

                                                               Isle of Man
                                                        

                                                               Italy
                                                        

                                                               Jersey
                                                        

                                                               Kosovo
                                                        

                                                               Latvia
                                                        

                                                               Liechtenstein
                                                        

                                                               Lithuania
                                                        

                                                               Luxembourg
                                                        

                                                               Macedonia
                                                        

                                                               Malta
                                                        

                                                               Moldova
                                                        

                                                               Monaco
                                                        

                                                               Netherlands
                                                        

                                                               Norway
                                                        

                                                               Poland
                                                        

                                                               Portugal
                                                        

                                                               Romania
                                                        

                                                               San Marino
                                                        

                                                               Scotland
                                                        

                                                               Serbia and Montenegro
                                                        

                                                               Slovakia
                                                        

                                                               Slovenia
                                                        

                                                               Spain
                                                        

                                                               Sweden
                                                        

                                                               Switzerland
                                                        

                                                               Ukraine
                                                        

                                                               United Kingdom
                                                        

                                                            Global
                                                        

                                                            Middle East
                                                        

                                                               Bahrain
                                                        

                                                               Cyprus
                                                        

                                                               Gaza Strip
                                                        

                                                               Iran
                                                        

                                                               Iraq
                                                        

                                                               Israel
                                                        

                                                               Jordan
                                                        

                                                               Kuwait
                                                        

                                                               Lebanon
                                                        

                                                               Oman
                                                        

                                                               Palestinian Territories
                                                        

                                                               Qatar
                                                        

                                                               Saudi Arabia
                                                        

                                                               Syria
                                                        

                                                               United Arab Emirates
                                                        

                                                               Yemen
                                                        

                                                            North America
                                                        

                                                               Bermuda
                                                        

                                                               Canada
                                                        

                                                               Greenland
                                                        

                                                               Mexico
                                                        

                                                               United States
                                                        

                                                            Oceania
                                                        

                                                               American Samoa
                                                        

                                                               Australia
                                                        

                                                               Cook Islands
                                                        

                                                               Fiji
                                                        

                                                               French Polynesia
                                                        

                                                               Guam
                                                        

                                                               Kiribati
                                                        

                                                               Marshall Islands
                                                        

                                                               Micronesia, Federated States of
                                                        

                                                               Nauru
                                                        

                                                               New Caledonia
                                                        

                                                               New Zealand
                                                        

                                                               Niue
                                                        

                                                               Norfolk Island
                                                        

                                                               Northern Mariana Islands
                                                        

                                                               Palau
                                                        

                                                               Samoa
                                                        

                                                               Solomon Islands
                                                        

                                                               Tonga
                                                        

                                                               Tuvalu
                                                        

                                                               Vanuatu
                                                        

                                                            South America
                                                        

                                                               Argentina
                                                        

                                                               Bolivia
                                                        

                                                               Brazil
                                                        

                                                               Chile
                                                        

                                                               Colombia
                                                        

                                                               Ecuador
                                                        

                                                               Falkland Islands
                                                        

                                                               French Guiana
                                                        

                                                               Guyana
                                                        

                                                               Paraguay
                                                        

                                                               Peru
                                                        

                                                               Suriname
                                                        

                                                               Uruguay
                                                        

                                                               Venezuela
                                                        





 Search 











Global Cancer Diagnostics Market Overview 2021: Test Volume and Sales Forecasts by Country, Laboratory Universe
Jul 26, 2017  | USD 2,450
...etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The ... Read More


Europe Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
Jul 26, 2017  | USD 6,900
...analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts ... Read More


Tumor Markers Testing Instrumentation Review: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
Jul 26, 2017  | USD 3,850
...testing. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&amp;D, collaborative arrangements and business strategies. Contains ... Read More


Cancer Diagnostic Instrumentation Review: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers
Jul 26, 2017  | USD 3,850
...testing. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&amp;D, collaborative arrangements and business strategies. ... Read More


Global Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
Jul 26, 2017  | USD 9,500
...analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test ... Read More


Cervical Cancer Test Market & Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA) - Global Forecast to 2022
Jul 24, 2017  | USD 1,890
...all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions ... Read More


Georgia Pharmaceuticals and Healthcare Report Q3 2017
Jul 19, 2017  | USD 1,345
...entice drugmakers to invest in manufacturing facilities the country because of the attractivebusiness environment. Domestic challenges, including the lack of pricing regulation, will pose uniquechallenges for drugmakers exporting into the market. Headline Expenditure Projections Pharmaceuticals: ... Read More


Europe Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...is estimated to increase from $434.7 million in 2016 and reach $738.73 million by 2025. MARKET INSIGHTS The market has plenty of growth opportunities owing to the unmet needs of CIC drugs in certain countries. ... Read More


Global Biopreservation Market 2017-2021
Jul 19, 2017  | USD 3,500
...extended period. Earlier, in the field of tissue engineering, cell and tissue transplantation, and genetic engineering, and preserving of engineered cells and tissues with functional viability in an external environment is a major challenge. Technavio’s ... Read More


Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 2,500
...propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market. MARKT INSIGHT The ... Read More


Indonesia Pharmaceuticals and Healthcare Report Q3 2017
Jul 19, 2017  | USD 1,345
...overall operating climate will remain hampered byunresolved patent protection issues as well as by the deceleration of the universal healthcare programme. Headline Expenditure Projections Pharmaceuticals: IDR86trn (USD6.4bn) in 2016 to IDR94trn (USD6.9bn) in 2017; +10.1% ... Read More


Asia-pacific Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...by the market is expected to rise from $303.4 million in 2016 and reach $ 502.4 million by 2025. MARKET INSIGHTS The Asian CIC drug market can be segmented by the type of drug and ... Read More


North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...rise from $818 million in 2016 to $1527.50 million by 2025. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of ... Read More


Global Veterinary Clostridium Vaccine Market 2017-2021
Jul 19, 2017  | USD 3,500
...of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are ... Read More


Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...approximately 8 molecules are developed by companies and remaining by the universities/institutes. The latest report Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2017, outlays comprehensive information on the Respiratory ... Read More


Degenerative Disc Disease - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...Disease (Musculoskeletal Disorders) pipeline landscape. Degenerative disc disease is refers to degeneration of intervertebral discs of the spinal column. The main symptom of degenerative disc disease is pain, which often worsens during certain types of ... Read More


Erectile Dysfunction - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, ... Read More


China Human Vaccine Industry Report, 2017-2021
Jul 18, 2017  | USD 2,800
...Mar 2016 in Shandong, the country’s lot release volume of human vaccines came to 553.6 million doses through the year 2016, down 3.8% over the previous year. The lot release volume of ten vaccines (Hepatitis ... Read More


Hypoglycemia - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, and irritability, feelings of hunger, weakness, tiredness, dizziness, headache, confusion, and trouble concentrating. Risk factors ... Read More


Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...Review, H2 2017 Summary Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC ... Read More


5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...EC 3.1.3.5) - Pipeline Review, H2 2017'; 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) pipeline Target constitutes close to 11 molecules. Out of which approximately 8 molecules are developed by ... Read More


Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...H2 2017'; Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and ... Read More


Botulism - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...is a rare but serious illness. The cause is a toxin (poison) made by a bacterium called Clostridium botulinum. It occurs naturally in soil. Food borne botulism comes from eating foods contaminated with the toxin. ... Read More


Diabetic Peripheral Neuropathy - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legs and feet is known as diabetic peripheral neuropathy. Symptoms include numbness or ... Read More


Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...(Scleroderma) (Immunology) pipeline landscape. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pains, joint pain and swelling, ulcers occurring on fingertips, ... Read More



< prev 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
  next > 




Start New Browse


Consumer Goods
Food & Beverage
Heavy Industry
Life Sciences
Marketing & Market Research
Public Sector
Service Industries
Technology & Media
 Company Reports
Reports by Country
View all Market Areas
View all Publishers






































Medgenics Inc. - Product Pipeline Review - 2015 - RnR Market Research












































Advanced search


1 888 391 5441

sales@rnrmarketresearch.com


Search Market Research Reports






 
 
﻿  Market Research Assistance+ 1-888-391-5441sales@rnrmarketresearch.com

On the Web       

Related Markets
BiotechnologyBiomaterialsBiomarkersStem CellDrug DiscoveryIndustrial BiotechnologyWound CareEnzymeMicroarrayBiopharmaceuticalCell Culture
Related Market ReportsMedgenics Inc. - Product Pipeline Review - 2014



Home  
 > Life Sciences > Biotechnology > Report Detail


 

Medgenics Inc. - Product Pipeline Review - 2015


Publisher Name :
Global Markets Direct
 Date: 30-Sep-2015
No. of pages: 26







Price:

Single User License: US $1500
Corporate User License: US $4500






 
Report DescriptionTable of ContentNews & BlogOther ReportsOur Offerings




Global Markets Direct's, Medgenics Inc. - Product Pipeline Review - 2015', provides an overview of the Medgenics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medgenics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Medgenics Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Medgenics Inc.'s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Medgenics Inc.'s pipeline products

Reasons to buy

Evaluate Medgenics Inc.'s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Medgenics Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Medgenics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Medgenics Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medgenics Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Medgenics Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues


Medgenics Inc. - Product Pipeline Review - 2015
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Medgenics Inc. Snapshot 5
Medgenics Inc. Overview 5
Key Information 5
Key Facts 5
Medgenics Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Medgenics Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Medgenics Inc. - Pipeline Products Glance 10
Medgenics Inc. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Medgenics Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Medgenics Inc. - Drug Profiles 13
MDGN-201 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NFC-1 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MDGN-204 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
MDGN-205 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
MDGN-206 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Medgenics Inc. - Pipeline Analysis 19
Medgenics Inc. - Pipeline Products by Target 19
Medgenics Inc. - Pipeline Products by Route of Administration 20
Medgenics Inc. - Pipeline Products by Molecule Type 21
Medgenics Inc. - Pipeline Products by Mechanism of Action 22
Medgenics Inc. - Recent Pipeline Updates 23
Medgenics Inc. - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26

List of Tables

Medgenics Inc., Key Information 5
Medgenics Inc., Key Facts 5
Medgenics Inc. - Pipeline by Indication, 2015 7
Medgenics Inc. - Pipeline by Stage of Development, 2015 8
Medgenics Inc. - Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. - Phase II, 2015 10
Medgenics Inc. - Phase I, 2015 11
Medgenics Inc. - Preclinical, 2015 12
Medgenics Inc. - Pipeline by Target, 2015 19
Medgenics Inc. - Pipeline by Route of Administration, 2015 20
Medgenics Inc. - Pipeline by Molecule Type, 2015 21
Medgenics Inc. - Pipeline Products by Mechanism of Action, 2015 22
Medgenics Inc. - Recent Pipeline Updates, 2015 23
Medgenics Inc., Other Locations 24
Medgenics Inc., Subsidiaries 24

List of Figures

Medgenics Inc. - Pipeline by Top 10 Indication, 2015 7
Medgenics Inc. - Pipeline by Stage of Development, 2015 8
Medgenics Inc. - Monotherapy Products in Pipeline, 2015 9
Medgenics Inc. - Pipeline by Top 10 Target, 2015 19
Medgenics Inc. - Pipeline by Top 10 Route of Administration, 2015 20
Medgenics Inc. - Pipeline by Top 10 Molecule Type, 2015 21
Medgenics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 22




High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market  The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …Foremost Trends In Global Pet Care Market The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…China To Review Its Food Security Laws  China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…Improving Standards Of Living To Boost Global Consumer Durables Market  Consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time. Profits in the consumer durables sector were most profoundly…

United States Gene Synthesis Market Report 2017

Published:  21-Jul-2017        Price: US 3800 Onwards        Pages: 111 
In this report, the United States Gene Synthesis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
with sales (volume), revenue (value), market share and growth rate of G......

EMEA (Europe, Middle East and Africa) Digital PCR and Real-time PCR (qPCR) Market Report 2017

Published:  21-Jul-2017        Price: US 4000 Onwards        Pages: 110 
In this report, the EMEA Digital PCR and Real-time PCR (qPCR) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Unit), revenue (Million USD), market share and growth rate of Digital PCR and Real-time PCR (qPCR) for these regions, from 2012 to 2022 (forecast)
- Europe: Germany, Franc......

Global Electrophoresis Market Research Report 2017

Published:  21-Jul-2017        Price: US 2900 Onwards        Pages: 120 
In this report, the global Electrophoresis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Electrophoresis in these regions, from 2012 to 2022 (forecast), covering
- North America
- Europe
- China
- Jap......

EMEA (Europe, Middle East and Africa) Microbial Growth Media Market Report 2017

Published:  21-Jul-2017        Price: US 4000 Onwards        Pages: 108 
In this report, the EMEA Microbial Growth Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Microbial Growth Media for these regions, from 2012 to 2022 (forecast)
- Europe: Germany, France, UK, Russia, Italy and Benel......

Global Digital PCR Market Research Report 2017

Published:  20-Jul-2017        Price: US 2900 Onwards        Pages: 108 
In this report, the global Digital PCR market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Digital PCR in these regions, from 2012 to 2022 (forecast), covering
- North America
- Europe
- China
- Japan......

Global Cell-based Assays Market Research Report 2017

Published:  20-Jul-2017        Price: US 2900 Onwards        Pages: 129 
In this report, the global Cell-based Assays market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cell-based Assays in these regions, from 2012 to 2022 (forecast), covering
- North America
- Europe
- China
-......

Global DNA Forensic Market Research Report 2017

Published:  20-Jul-2017        Price: US 2900 Onwards        Pages: 115 
In this report, the global DNA Forensic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of DNA Forensic in these regions, from 2012 to 2022 (forecast), covering
- North America
- Europe
- China
- Japan......

Global Microbial Identification Sales Market Report 2017

Published:  20-Jul-2017        Price: US 4000 Onwards        Pages: 117 
In this report, the global Microbial Identification market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Microbial Identification for these regions, from 2012 to 2022 (forecast), covering
- United States
- China
- Europe......

Global Biopreservation Market 2017-2021

Published:  19-Jul-2017        Price: US 3500 Onwards        Pages: 81 
Bio preservation is a process that uses effective storage techniques to preserve the indigenous functionality and integrity of cells, tissues, and organs at different temperatures for an extended period. Earlier, in the field of tissue engineering, cell and tissue transplantation, and genetic engineering, and preserving of engineered cells and tissues with functional viability in an external environment is a major challenge.
The analysts forecast global bio preservation market to grow......


SERVICES

Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.

Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.

One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.

Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.

Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.

Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.

Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )

Ad Hoc
Pay - as - you - go / Bucket Subscriptions
Fixed Cost for #of reports
Customize / Personalize as per your needs


















 Avail upto 25% Discount on below Publisher Reports.
   
Azoth Analytics 
Technavio













Biotechnology Market Research Reports on Market Size and Competitive Analysis











































Advanced search


1 888 391 5441

sales@rnrmarketresearch.com


Search Market Research Reports






 Market Research Assistance+ 1-888-391-5441sales@rnrmarketresearch.comOn the Web       

Refine ResultBy DateLast MonthLast 3 MonthsLast 6 MonthsLast YearLast 2 Years
By Price< $1000$1000-$2500$2501-$4000$4001-$5500$5501-$7500$7501-$9000>$9000





Home
  >  Life Sciences  >  Biotechnology 




Biotechnology Market Research Reports 

 

Biotechnology, the branch of applied biology that uses biological processes for medicine,engineering, technology, industrial and other purposes. The Biotechnology uses in major areas including, Cloning, Reproductive cloning, therapeutic cloning, environmental biotechnology, genetic engineering, recombinant DNA, tissue engineering and pharmaceutical manufacturing.

The biotechnology market is mainly driven by favorable government initiatives, increasing economic conditions, easily accessibility of funding for R&D, increasing use of biotechnology in medical sciences and agriculture.
The global biotechnology industry is moulded by growth of flexible clinical trial designs, healthcare reform legislation, growing use of healthcare infrastructure, medical device and pharmaceutical taxes and greater  involvement of private companies in biotechnology market.

The market is also registerd growth in mergers and acquisitions followed by patent expiration of various blockbuster drugs and laun...View More
Biotechnology, the branch of applied biology that uses biological processes for medicine,engineering, technology, industrial and other purposes. The Biotechnology uses in major areas including, Cloning, Reproductive cloning, therapeutic cloning, environmental biotechnology, genetic engineering, recombinant DNA, tissue engineering and pharmaceutical manufacturing.

The biotechnology market is mainly driven by favorable government initiatives, increasing economic conditions, easily accessibility of funding for R&D, increasing use of biotechnology in medical sciences and agriculture.
The global biotechnology industry is moulded by growth of flexible clinical trial designs, healthcare reform legislation, growing use of healthcare infrastructure, medical device and pharmaceutical taxes and greater  involvement of private companies in biotechnology market.

The market is also registerd growth in mergers and acquisitions followed by patent expiration of various blockbuster drugs and launching  of newer healthcare regulations. The small companies attempt to 
divest their operation or signed the licensing collaborations and partnerships with the larger companies.

The biotechnology industry is shaped by Human health, followed by agriculture, food, industrial applications and environmental sciences. The investments are made largely in discovery of new drugs and therapies including Cardiology, oncology, diabetes, hormone treatment, antiviral antibody, anemia and inflammation.

The market is led by US, followed by advanced European countries such as UK, France, Spain and Germany and developing countries, particularly India and China. India and China rising as central markets for biotech drugs due to low cost of investment and ample talent pool.

Also, the market is facing several problems such as the smaller companies continue to face problems in raising funds for R&D purposes and poor patent protection for biotech drug makers.View Less


BiochemicalEnzymeBiomaterialsDNA SequencingCell CultureStem CellBiopharmaceuticalDrug DiscoveryWound CareMicroarrayBiomarkersTissue EngineeringRNAi TechnologyProteomicAntibody TechnologyMolecular BiologyGene TherapyAgriculture BiotechnologyGenomicNanomedicineIndustrial BiotechnologyBioinformaticsGenetic EngineeringInformaticAntisense TechnologyEnvironmental Biotechnology

Biotechnology Market Research Reports 

Titlepublishedprice

2017-2022 United States 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... >

In United States market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated......"25-Jul-2017$3360

2017-2022 Philippines 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... 

In Philippines market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated
-......"25-Jul-2017$3360

2017-2022 Malaysia 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... r />
In Malaysia market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated
- 3D Bi......"25-Jul-2017$3360

2017-2022 Japan 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... >
In Japan market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated
- 3D Biotek......"25-Jul-2017$3360

2017-2022 India 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... >
In India market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated
- 3D Biotek......"25-Jul-2017$3360

2017-2022 Global Top Countries 3D Cell Culture Market ReportBy LP Information INC"...... 
This report studies 3D Cell Culture in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa,
focuses on the top M......"25-Jul-2017$4960

2017-2022 China 3D Cell Culture Market Report (Status and Outlook)By LP Information INC"...... >
In China market, the top players include
- Thermo Fisher Scientific
- Corning
- Lonza Group
- Kuraray Co
- Merck Kgaa
- Insphero
- N3d Bioscience
- Reprocell Incorporated
- 3D Biotek......"25-Jul-2017$3360

2017 Top 5 3D Cell Culture Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and AfricaBy LP Information INC"...... 
This report studies 3D Cell Culture in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 3D Cell Culture Players in each region, with sales, price, revenue and market share ......"25-Jul-2017$4960

Global and Europe Marine Biotechnology Market - Analysis and Outlook to 2022By QYResearch Group"...... in players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Marine Biotechnology industry.

This report focus Global and Europe market, it covers details players region......"25-Jul-2017$2960

Asia-Pacific Next Generation Sequencing Market Report 2017By QYResearch Group"...... with sales (K Units), revenue (Million USD), market share and growth rate of Next Generation Sequencing for these regions, from 2012 to 2022 (forecast), including
- China
- Japan
- South Korea
- Taiwan
- India......"24-Jul-2017$4000
 
1 | 2 | 3 | 4 | 5 | 6 | 7 | ...367 | 368next »

 








 Avail upto 25% Discount on below Publisher Reports.
   
Azoth Analytics 
Technavio














Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Plus Size Clothing for Women - Macy's



















































  







       Sign In   Stores  Book An Appointment Find a Store Find an Event   Stores Customer Service                                               my bag (0)       WOMEN     Women's Clothing   Activewear   Basic Clothing   Blazers   Capris   Coats   Dresses   Jackets   Jeans   Jumpsuits & Rompers   Leggings   Lingerie & Shapewear   Maternity   Pajamas & Robes   Pants   Shorts   Skirts   Suits & Suit Separates   Sweaters   Swimwear   Tights, Socks, & Hosiery   Tops   Wear to Work       Plus Sizes   Dresses   Pants & Capris   Swimwear   Tops   Trendy Plus Size   All Plus Sizes     Petites   Cardigans   Dresses   Jeans   Pants & Capris   Tops   All Petites     New & Now   Avec Les Filles   Bare Shoulder   Graphic Tees & Sweatshirts   New Arrivals   Soft Pant   Trend Shop       Women's Brands   Adrianna Papell   Alfani   Calvin Klein   Charter Club   INC International Concepts   Lauren Ralph Lauren   MICHAEL Michael Kors   Nike   Style & Co   The Fur Vault   The North Face   Tommy Hilfiger   Under Armour   Vince Camuto   See All Brands     Featured Shops   Cashmere Shop   Dress Edit   Must Haves   Petite Fit Guide   Plus Must Haves & Fit Guide   Sports Fan Shop By Lids   Swim Finder   The Wedding Shop       Contemporary Brands   Bar III   Free People   Levi's   Lucky Brand   RACHEL Rachel Roy   All Contemporary Clothing     Designer Brands   Eileen Fisher   Polo Ralph Lauren   All Designer Clothing     Shoes, Handbags, & More   Beauty   Handbags   Belts, Hats & Scarves   Jewelry & Watches   Shoes   Sunglasses   Tech Shop     Pop-Up Sale   40-70% off Clearance      MEN  HOME  BED & BATH  SHOES  HANDBAGS  BEAUTY  KIDS  JUNIORS  JEWELRY  WATCHES  ACTIVE  BRANDS      Wedding Registry Gift Cards Deals & Promotions Lists                RTP header-xapi 07/26/2017 02:01:30 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 




Popular Searches
Bathing Suits Calvin Klein Calvin Klein Dresses Lauren Ralph Lauren Women's Michael Kors Nike Women's Tommy Hilfiger Women's Tops - Plus Size Women's Dresses Women's Tops



Plus Size ClothingLooking for an amazing selection of plus size clothes for women? There are so many styles, colors and brands waiting for you to discover. Shop stylish options for all occasions and find many pieces available in fun, vibrant colors such as sizzling confident red, warm blush pink, and soft, feminine purple.
For casual day-to-day outfits, find cute and comfortable tops along with figure flattering plus size jeans. A pair of slim rocker boot-cut blue jeans from Seven7 pairs matches well with a blouse, tee-shirt, sweater or jacket. For plus size clothing for women with dramatic contrast and just as much comfort, slip into some straight leg black wash jeans from Not Your Daughter's Jeans. And go feminine chick with a long sleeve shawl in luxurious cashmere. Get great tops for any season from tank tops to sweaters.
Polish your work wardrobe with sharp and sophisticated plus size pant suits and skirt suits. Mix and match suit separates from Anne Klein blazers with bottoms of our choice. Look for slimming pinstripe trousers or office appropriate pencil skirts in extended sizes. Tahari offers lovely textured jackets and Kasper Suits features beautiful prints.
Find a wonderful selection of dressy plus size clothes for women. Start a special evening out by slipping into dazzling formalwear or add some eye catching contrast with a one-shouldered a-line dress from International Concepts. Ruby Rox carries plus size dresses for attending an evening event or a wedding. For more casual occasions and day-to-day wear, look for dresses that can be worn to work or to a dinner date.
From suit jackets to halter tops and evening gowns to jeans, you'll find fashionable plus size clothing for women you're looking for at macys.com. Shop at Macy’s for the latest trends in regular and extended sizes.












To ensure you're getting the best shopping experience, please enable JavaScript in your browser preferences.








Plus Sizes



pop-up sale


40-70% off clearance


plus size clothing


Activewear


Coats


Dresses


Graphic Tees


Jackets & Blazers


Jeans


Jumpsuits & Rompers


Leggings


Lingerie & Shapewear


Maternity


Pajamas & Robes


Pants & Capris


Shorts


Skirts


Suits & Suit Separates


Sweaters


Swimwear


Tops


Trendy Plus Sizes


Vests


Wear to Work




petite plus size


All Petite Plus Size





plus size brands



Alfani



Alfani



Anne Klein



Anne Klein



Calvin Klein



Calvin Klein



Charter Club



Charter Club



City Chic



City Chic



INC International Concepts



INC International Concepts



Lauren Ralph Lauren



Lauren Ralph Lauren



MICHAEL Michael Kors



MICHAEL Michael Kors



Style & Co



Style & Co



Tommy Hilfiger



Tommy Hilfiger




Rachel Rachel Roy Curvy Collection




American Rag




Jessica Simpson




JM Collection




Karen Scott




Melissa McCarthy Seven7




Silver Jeans




Celebrity Pink Plus




Jones New York




Levi's




Lucky Brand Jeans




Tahari ASL




Ideology




Material Girl




SLINK Jeans




mblm by Tess Holliday



See All Brands




featured shops


#macyslove Photo Gallery


Back To School


Denim Destination


Dress Edit


How to Wear it


Must Haves & Fit Guide


The Wedding Shop




shoes & accessories


Handbags & Accessories


Hats, Scarves & Wraps


Hosiery


Shoes


Sunglasses




plus size sale & clearance






 







10

























 
























Shop our Ultimate Pop-Up Sale










40-75% Off Select Tops







40-75% Off Select Shorts & Capris







40-75% Off Select Dresses







25-40% off Trendy Plus & Designer






















Tops














Dresses























Pants & Capris














Cardigans























Swim














Shorts























Jeans














Jackets & Blazers


































































































 





































 













Overview







Read all reviews








or call 1 800 BUY MACY (289 6229)


See Full Product Details



Qty:



















32147
Plus Sizes
QUICKVIEW

 


































 







  MCOM footer-xapi 07/26/2017 02:07:19 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 
















































RTP
catalog -
catSplash
Page Layout - Canvas
macys-navapp_replica_prod_cellA_ma100mlvnav005_m01
MA100MLVNAV005
07/26/2017 02:37:26 EDT
17L
 Sat Jul 8 01:05:37 UTC 2017
2.81.39




#GoYou | Macy's Health & Fitness Guide – Macy's





MACY'SIS YOURCENTERFOR EATING,LIVING &BEING WELLIN THE 21stCENTURY#GOYOUSTRENGTHEN YOUR FORMNOURISH YOUR BODYRESTORE YOUR SOULCHOOSE WHAT MAKES YOU SWEAT:TRAININGWOMENMENRUNNINGWOMENMENOUTDOORSWOMENMENGOLFWOMENMENFINISH LINEOUT AND ABOUT IN THE LATESTWOMENMENKIDSBRANDS WE LOVENOURISHWe all know health is an inside job. It's time to hit the kitchen.SHOP THE ESSENTIALSTOP 10 NOURISH PICKS  
	                                FEATURED CATEGORIESJuicersBlendersWater BottlesCulinary CouncilCookware & ElectricsKitchen GadgetsBRANDS WE LOVETIPS FOR A HEALTHIERNEW YEARWhether you resolved to lose weight or simply want to fuel up for a busy day, check out these tips from the Macy's Culinary Council.CHECK IT OUTRESTORER&R speeds up recovery. Here's how to treat yourself better.SHOP THE ESSENTIALSTOP 10 RESTORE PICKS FEATURED CATEGORIESSunscreens & LotionsMattressesSleep SolutionsAir PurifiersPersonal CareSport SunglassesBRANDS WE LOVE×
	                Your browser does not support the video tag. 
	            








